Industry Research Reports

Home > Reports > Medical Care > Companion Diagnostic Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Companion Diagnostic Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 91 Pages

Report ld: 2332966

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Companion Diagnostic Tests was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Companion Diagnostic Tests by region & country, by Type, and by Application.

The Companion Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic Tests.

Market Segmentation

Report Metric
Details
Report Title
Companion Diagnostic Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Companion Diagnostic Tests Companies Covered
F. Hoffman LA Roche Ltd., QIAGEN, Illumina, Inc., Abbott, Agilent Technologies, Inc., Genomic Health, Inc., BioMerieux SA, BioGenex, AGENDIA NV, Siemens Healthcare GmBH, Thermo Fisher Scientific, Inc.
Global Companion Diagnostic Tests Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Companion Diagnostic Tests Market, Segment by Type
Protein Detection

DNA Detection

Hybridization

Biomarker

Others
Global Companion Diagnostic Tests Market, Segment by Application
Pharmaceutical and Biotechnology Companies

Medical Device Companies

Research Institutes
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Companion Diagnostic Tests manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Companion Diagnostic Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Companion Diagnostic Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Companion Diagnostic Tests Product Introduction
    1.2 Global Companion Diagnostic Tests Market Size Forecast
    1.3 Companion Diagnostic Tests Market Trends & Drivers
        1.3.1 Companion Diagnostic Tests Industry Trends
        1.3.2 Companion Diagnostic Tests Market Drivers & Opportunity
        1.3.3 Companion Diagnostic Tests Market Challenges
        1.3.4 Companion Diagnostic Tests Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Companion Diagnostic Tests Players Revenue Ranking (2023)
    2.2 Global Companion Diagnostic Tests Revenue by Company (2019-2024)
    2.3 Key Companies Companion Diagnostic Tests Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Companion Diagnostic Tests Product Offered
    2.5 Key Companies Time to Begin Mass Production of Companion Diagnostic Tests
    2.6 Companion Diagnostic Tests Market Competitive Analysis
        2.6.1 Companion Diagnostic Tests Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Companion Diagnostic Tests Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Protein Detection
        3.1.2 DNA Detection
        3.1.3 Hybridization
        3.1.4 Biomarker
        3.1.5 Others
    3.2 Global Companion Diagnostic Tests Sales Value by Type
        3.2.1 Global Companion Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Companion Diagnostic Tests Sales Value, by Type (2019-2030)
        3.2.3 Global Companion Diagnostic Tests Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Pharmaceutical and Biotechnology Companies
        4.1.2 Medical Device Companies
        4.1.3 Research Institutes
    4.2 Global Companion Diagnostic Tests Sales Value by Application
        4.2.1 Global Companion Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Companion Diagnostic Tests Sales Value, by Application (2019-2030)
        4.2.3 Global Companion Diagnostic Tests Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Companion Diagnostic Tests Sales Value by Region
        5.1.1 Global Companion Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Companion Diagnostic Tests Sales Value by Region (2019-2024)
        5.1.3 Global Companion Diagnostic Tests Sales Value by Region (2025-2030)
        5.1.4 Global Companion Diagnostic Tests Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Companion Diagnostic Tests Sales Value, 2019-2030
        5.2.2 North America Companion Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Companion Diagnostic Tests Sales Value, 2019-2030
        5.3.2 Europe Companion Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Companion Diagnostic Tests Sales Value, 2019-2030
        5.4.2 Asia Pacific Companion Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Companion Diagnostic Tests Sales Value, 2019-2030
        5.5.2 South America Companion Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Companion Diagnostic Tests Sales Value, 2019-2030
        5.6.2 Middle East & Africa Companion Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Companion Diagnostic Tests Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Companion Diagnostic Tests Sales Value
    6.3 United States
        6.3.1 United States Companion Diagnostic Tests Sales Value, 2019-2030
        6.3.2 United States Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Companion Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Companion Diagnostic Tests Sales Value, 2019-2030
        6.4.2 Europe Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Companion Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Companion Diagnostic Tests Sales Value, 2019-2030
        6.5.2 China Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Companion Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Companion Diagnostic Tests Sales Value, 2019-2030
        6.6.2 Japan Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Companion Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Companion Diagnostic Tests Sales Value, 2019-2030
        6.7.2 South Korea Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Companion Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Companion Diagnostic Tests Sales Value, 2019-2030
        6.8.2 Southeast Asia Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Companion Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Companion Diagnostic Tests Sales Value, 2019-2030
        6.9.2 India Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Companion Diagnostic Tests Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 F. Hoffman LA Roche Ltd.
        7.1.1 F. Hoffman LA Roche Ltd. Profile
        7.1.2 F. Hoffman LA Roche Ltd. Main Business
        7.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Products, Services and Solutions
        7.1.4 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue (US$ Million) & (2019-2024)
        7.1.5 F. Hoffman LA Roche Ltd. Recent Developments
    7.2 QIAGEN, Illumina, Inc.
        7.2.1 QIAGEN, Illumina, Inc. Profile
        7.2.2 QIAGEN, Illumina, Inc. Main Business
        7.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Products, Services and Solutions
        7.2.4 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue (US$ Million) & (2019-2024)
        7.2.5 QIAGEN, Illumina, Inc. Recent Developments
    7.3 Abbott
        7.3.1 Abbott Profile
        7.3.2 Abbott Main Business
        7.3.3 Abbott Companion Diagnostic Tests Products, Services and Solutions
        7.3.4 Abbott Companion Diagnostic Tests Revenue (US$ Million) & (2019-2024)
        7.3.5 Agilent Technologies, Inc. Recent Developments
    7.4 Agilent Technologies, Inc.
        7.4.1 Agilent Technologies, Inc. Profile
        7.4.2 Agilent Technologies, Inc. Main Business
        7.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Products, Services and Solutions
        7.4.4 Agilent Technologies, Inc. Companion Diagnostic Tests Revenue (US$ Million) & (2019-2024)
        7.4.5 Agilent Technologies, Inc. Recent Developments
    7.5 Genomic Health, Inc.
        7.5.1 Genomic Health, Inc. Profile
        7.5.2 Genomic Health, Inc. Main Business
        7.5.3 Genomic Health, Inc. Companion Diagnostic Tests Products, Services and Solutions
        7.5.4 Genomic Health, Inc. Companion Diagnostic Tests Revenue (US$ Million) & (2019-2024)
        7.5.5 Genomic Health, Inc. Recent Developments
    7.6 BioMerieux SA, BioGenex
        7.6.1 BioMerieux SA, BioGenex Profile
        7.6.2 BioMerieux SA, BioGenex Main Business
        7.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Products, Services and Solutions
        7.6.4 BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue (US$ Million) & (2019-2024)
        7.6.5 BioMerieux SA, BioGenex Recent Developments
    7.7 AGENDIA NV
        7.7.1 AGENDIA NV Profile
        7.7.2 AGENDIA NV Main Business
        7.7.3 AGENDIA NV Companion Diagnostic Tests Products, Services and Solutions
        7.7.4 AGENDIA NV Companion Diagnostic Tests Revenue (US$ Million) & (2019-2024)
        7.7.5 AGENDIA NV Recent Developments
    7.8 Siemens Healthcare GmBH
        7.8.1 Siemens Healthcare GmBH Profile
        7.8.2 Siemens Healthcare GmBH Main Business
        7.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Products, Services and Solutions
        7.8.4 Siemens Healthcare GmBH Companion Diagnostic Tests Revenue (US$ Million) & (2019-2024)
        7.8.5 Siemens Healthcare GmBH Recent Developments
    7.9 Thermo Fisher Scientific, Inc.
        7.9.1 Thermo Fisher Scientific, Inc. Profile
        7.9.2 Thermo Fisher Scientific, Inc. Main Business
        7.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Products, Services and Solutions
        7.9.4 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue (US$ Million) & (2019-2024)
        7.9.5 Thermo Fisher Scientific, Inc. Recent Developments

 8 Industry Chain Analysis
    8.1 Companion Diagnostic Tests Industrial Chain
    8.2 Companion Diagnostic Tests Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Companion Diagnostic Tests Sales Model
        8.5.2 Sales Channel
        8.5.3 Companion Diagnostic Tests Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Companion Diagnostic Tests Market Trends
    Table 2. Companion Diagnostic Tests Market Drivers & Opportunity
    Table 3. Companion Diagnostic Tests Market Challenges
    Table 4. Companion Diagnostic Tests Market Restraints
    Table 5. Global Companion Diagnostic Tests Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Companion Diagnostic Tests Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Companion Diagnostic Tests Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Companion Diagnostic Tests Product Type
    Table 9. Key Companies Time to Begin Mass Production of Companion Diagnostic Tests
    Table 10. Global Companion Diagnostic Tests Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Companion Diagnostic Tests Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Companion Diagnostic Tests Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Companion Diagnostic Tests Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Companion Diagnostic Tests Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Companion Diagnostic Tests Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Companion Diagnostic Tests Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Companion Diagnostic Tests Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Companion Diagnostic Tests Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Companion Diagnostic Tests Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Companion Diagnostic Tests Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Companion Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Companion Diagnostic Tests Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Companion Diagnostic Tests Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Companion Diagnostic Tests Sales Value by Region (2019-2024) & (%)
    Table 27. Global Companion Diagnostic Tests Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Companion Diagnostic Tests Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Companion Diagnostic Tests Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Companion Diagnostic Tests Sales Value, (2025-2030) & (US$ Million)
    Table 31. F. Hoffman LA Roche Ltd. Basic Information List
    Table 32. F. Hoffman LA Roche Ltd. Description and Business Overview
    Table 33. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Companion Diagnostic Tests Business of F. Hoffman LA Roche Ltd. (2019-2024)
    Table 35. F. Hoffman LA Roche Ltd. Recent Developments
    Table 36. QIAGEN, Illumina, Inc. Basic Information List
    Table 37. QIAGEN, Illumina, Inc. Description and Business Overview
    Table 38. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Companion Diagnostic Tests Business of QIAGEN, Illumina, Inc. (2019-2024)
    Table 40. QIAGEN, Illumina, Inc. Recent Developments
    Table 41. Abbott Basic Information List
    Table 42. Abbott Description and Business Overview
    Table 43. Abbott Companion Diagnostic Tests Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Companion Diagnostic Tests Business of Abbott (2019-2024)
    Table 45. Abbott Recent Developments
    Table 46. Agilent Technologies, Inc. Basic Information List
    Table 47. Agilent Technologies, Inc. Description and Business Overview
    Table 48. Agilent Technologies, Inc. Companion Diagnostic Tests Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Companion Diagnostic Tests Business of Agilent Technologies, Inc. (2019-2024)
    Table 50. Agilent Technologies, Inc. Recent Developments
    Table 51. Genomic Health, Inc. Basic Information List
    Table 52. Genomic Health, Inc. Description and Business Overview
    Table 53. Genomic Health, Inc. Companion Diagnostic Tests Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Companion Diagnostic Tests Business of Genomic Health, Inc. (2019-2024)
    Table 55. Genomic Health, Inc. Recent Developments
    Table 56. BioMerieux SA, BioGenex Basic Information List
    Table 57. BioMerieux SA, BioGenex Description and Business Overview
    Table 58. BioMerieux SA, BioGenex Companion Diagnostic Tests Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Companion Diagnostic Tests Business of BioMerieux SA, BioGenex (2019-2024)
    Table 60. BioMerieux SA, BioGenex Recent Developments
    Table 61. AGENDIA NV Basic Information List
    Table 62. AGENDIA NV Description and Business Overview
    Table 63. AGENDIA NV Companion Diagnostic Tests Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Companion Diagnostic Tests Business of AGENDIA NV (2019-2024)
    Table 65. AGENDIA NV Recent Developments
    Table 66. Siemens Healthcare GmBH Basic Information List
    Table 67. Siemens Healthcare GmBH Description and Business Overview
    Table 68. Siemens Healthcare GmBH Companion Diagnostic Tests Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Companion Diagnostic Tests Business of Siemens Healthcare GmBH (2019-2024)
    Table 70. Siemens Healthcare GmBH Recent Developments
    Table 71. Thermo Fisher Scientific, Inc. Basic Information List
    Table 72. Thermo Fisher Scientific, Inc. Description and Business Overview
    Table 73. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Companion Diagnostic Tests Business of Thermo Fisher Scientific, Inc. (2019-2024)
    Table 75. Thermo Fisher Scientific, Inc. Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Companion Diagnostic Tests Downstream Customers
    Table 79. Companion Diagnostic Tests Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Companion Diagnostic Tests Product Picture
    Figure 2. Global Companion Diagnostic Tests Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Companion Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 4. Companion Diagnostic Tests Report Years Considered
    Figure 5. Global Companion Diagnostic Tests Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Companion Diagnostic Tests Revenue in 2023
    Figure 7. Companion Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Protein Detection Picture
    Figure 9. DNA Detection Picture
    Figure 10. Hybridization Picture
    Figure 11. Biomarker Picture
    Figure 12. Others Picture
    Figure 13. Global Companion Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Companion Diagnostic Tests Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Pharmaceutical and Biotechnology Companies
    Figure 16. Product Picture of Medical Device Companies
    Figure 17. Product Picture of Research Institutes
    Figure 18. Global Companion Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Companion Diagnostic Tests Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Companion Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Companion Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Companion Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Companion Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Companion Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Companion Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Companion Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Companion Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Companion Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Companion Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Companion Diagnostic Tests Sales Value (%), (2019-2030)
    Figure 31. United States Companion Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Companion Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Companion Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Companion Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Companion Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Companion Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Companion Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Companion Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Companion Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Companion Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Companion Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Companion Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Companion Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Companion Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Companion Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 52. Companion Diagnostic Tests Industrial Chain
    Figure 53. Companion Diagnostic Tests Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation

Description

The global market for Companion Diagnostic Tests was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Companion Diagnostic Tests by region & country, by Type, and by Application.

The Companion Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic Tests.

Market Segmentation